Concepedia

ChlVPP/EVA Hybrid Versus the Weekly VAPEC-B Regimen for Previously Untreated Hodgkin’s Disease

John Radford, A. Z. S. Rohatiner, W. David J. Ryder, D.P. Deakin, Tiziano Barbui, N.P. Lucie, Andrea Rossi, DJ Dunlop, Richard Cowan, P M Wilkinson,

Journal of Clinical Oncology · 2002 · 80 citations · 24 references

DOI

Abstract

Apart from possibly in the best-prognosis group, where results are equivalent, ChlVPP/EVA hybrid produces significantly better FFP, EFS, and OS than VAPEC-B in patients with previously untreated Hodgkin's disease.

References

24

A Prognostic Score for Advanced Hodgkin's Disease

Dirk Hasenclever, Volker Diehl, Jamés O. Armitage et al. · New England Journal of Medicine · 1998 · 1.7K citations · Full text

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

Tim Lister, D. Crowther, S.B. Sutcliffe et al. · Journal of Clinical Oncology · 1989 · 1.6K citations

, , +18

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

Vincent T. DeVita · Annals of Internal Medicine · 1970 · 1.4K citations

, , +16

Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD

George P. Canellos, James R. Anderson, Kathleen J. Propert et al. · New England Journal of Medicine · 1992 · 1.2K citations · Full text

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

Gianni Bonadonna, R Zucali, S. Monfardini et al. · Cancer · 1975 · 756 citations · Full text